Verywell Health on MSN13d
The 3 Types of Ovarian Cancer and How They Are DifferentThere are three main types of ovarian cancer: epithelial, germ cell, and stromal. Learn about each type’s defining ...
A comparison of patients with and without BRCA gene mutations receiving prophylactic risk-reduction surgery suggest ...
The phase 3 trial design evaluating IMNN-001 in newly diagnosed advanced ovarian cancer has been finalized among regulatory ...
The first patient was dosed in a phase 3 trial of IBI354 for platinum-resistant ovarian cancer with HER2 expression.
Innovent Biologics begins patient dosing in phase 3 study of IBI354 for platinum-resistant ovarian cancer: San Francisco Tuesday, March 25, 2025, 18:00 Hrs [IST] Innovent Biologic ...
Vietnam Investment Review on MSN3d
Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 for Platinum-resistant Ovarian CancerInnovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high quality ...
Anixa Biosciences gets notice of allowance for patent application for its ovarian cancer vaccine technology from USPTO: San Jose, California Thursday, March 27, 2025, 17:00 Hrs [I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback